142 related articles for article (PubMed ID: 3252751)
1. Pharmacokinetics and metabolism of rimantadine hydrochloride in mice and dogs.
Hoffman HE; Gaylord JC; Blasecki JW; Shalaby LM; Whitney CC
Antimicrob Agents Chemother; 1988 Nov; 32(11):1699-704. PubMed ID: 3252751
[TBL] [Abstract][Full Text] [Related]
2. Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults.
Hayden FG; Minocha A; Spyker DA; Hoffman HE
Antimicrob Agents Chemother; 1985 Aug; 28(2):216-21. PubMed ID: 3834831
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2.
Rees WA; Harkins JD; Lu M; Holland RE; Lehner AF; Tobin T; Chambers TM
Am J Vet Res; 1999 Jul; 60(7):888-94. PubMed ID: 10407485
[TBL] [Abstract][Full Text] [Related]
4. Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse.
Rees WA; Harkins JD; Woods WE; Blouin RA; Lu M; Fenger C; Holland RE; Chambers TM; Tobin T
Equine Vet J; 1997 Mar; 29(2):104-10. PubMed ID: 9104558
[TBL] [Abstract][Full Text] [Related]
5. Multiple-dose pharmacokinetics of rimantadine in elderly adults.
Tominack RL; Wills RJ; Gustavson LE; Hayden FG
Antimicrob Agents Chemother; 1988 Dec; 32(12):1813-9. PubMed ID: 3245694
[TBL] [Abstract][Full Text] [Related]
6. Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics.
Hayden FG; Hoffman HE; Spyker DA
Antimicrob Agents Chemother; 1983 Mar; 23(3):458-64. PubMed ID: 6847173
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of rimantadine hydrochloride in patients with chronic liver disease.
Wills RJ; Belshe R; Tomlinsin D; De Grazia F; Lin A; Wells S; Milazzo J; Berry C
Clin Pharmacol Ther; 1987 Oct; 42(4):449-54. PubMed ID: 3665342
[TBL] [Abstract][Full Text] [Related]
8. Rimantadine pharmacokinetics in healthy subjects and patients with end-stage renal failure.
Capparelli EV; Stevens RC; Chow MS; Izard M; Wills RJ
Clin Pharmacol Ther; 1988 May; 43(5):536-41. PubMed ID: 3365917
[TBL] [Abstract][Full Text] [Related]
9. Determination of rimantadine and its hydroxylated metabolites in human plasma and urine.
Rubio FA; Choma N; Fukuda EK
J Chromatogr; 1989 Dec; 497():147-57. PubMed ID: 2625452
[TBL] [Abstract][Full Text] [Related]
10. Effect of cimetidine on the disposition of rimantadine in healthy subjects.
Holazo AA; Choma N; Brown SY; Lee LF; Wills RJ
Antimicrob Agents Chemother; 1989 Jun; 33(6):820-3. PubMed ID: 2764530
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and metabolism of [14C]rosaramicin in dogs.
Lin CC; Kim HK; Marco A; Radwanski E; Symchowicz S
Antimicrob Agents Chemother; 1986 May; 29(5):753-6. PubMed ID: 3729339
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence of two rimantadine tablet formulations in healthy male volunteers after single dose administration.
Chládek J; Sispera L; Martinková J; Zaludek B; Sova P; Mièuda S; Grim J; Cermanová J; Zaludek B; Sova P; Franc A
Int J Clin Pharmacol Ther; 2001 Apr; 39(4):179-84. PubMed ID: 11332875
[TBL] [Abstract][Full Text] [Related]
13. The metabolism of [14C]rimantadine hydrochloride in rats and dogs.
Loh AC; Szuna AJ; Williams TH; Sasso GJ; Leinweber FJ
Drug Metab Dispos; 1991; 19(2):381-7. PubMed ID: 1676641
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a single dose of rimantadine in young adults and children.
Anderson EL; Van Voris LP; Bartram J; Hoffman HE; Belshe RB
Antimicrob Agents Chemother; 1987 Jul; 31(7):1140-2. PubMed ID: 3662473
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of the enantiomers of rimantadine in human plasma and urine by gas chromatography-mass spectrometry.
Miwa BJ; Choma N; Brown SY; Keigher N; Garland WA; Fukuda EK
J Chromatogr; 1988 Oct; 431(2):343-52. PubMed ID: 3243789
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of rimantadine hydrochloride in the treatment of influenza infection of mice.
Herrmann JE; Bruns M; West K; Ennis FA
Antiviral Res; 1989 Apr; 11(3):127-35. PubMed ID: 2735758
[TBL] [Abstract][Full Text] [Related]
17. Quantitative determination of rimantadine in human plasma and urine by GC-MS.
Fukuda EK; Rodriguez LC; Choma N; Keigher N; De Grazia F; Garland WA
Biomed Environ Mass Spectrom; 1987 Oct; 14(10):549-53. PubMed ID: 2962655
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
19. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
20. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
